ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes

The expression of receptors belonging to the epidermal growth factor receptor subfamily has been largely studied these last years in epithelial cells mainly as involved in cell proliferation and malignant progression. Although much work has focused on the role of these growth factor receptors in the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pagano, E., Calvo, J.C.
Formato:	JOUR
Materias:	3T3-L1 cells Adipocyte differentiation CAMP Dexamethasone EGF EGFR ErbB2 Fibroblasts Heregulin Insulin Tyrosine phosphorylation dexamethasone epidermal growth factor receptor growth factor receptor growth hormone heregulin alpha1 heregulin beta1 methylxanthine derivative neu differentiation factor thyroid hormone unclassified drug adipocyte animal cell article cell differentiation cell migration cell proliferation controlled study epithelium cell malignant transformation mitogenesis nonhuman oncogene neu polyacrylamide gel electrophoresis priority journal proadipocyte protein expression protein phosphorylation 3T3-L1 Cells Adipocytes Animals Cell Differentiation Epidermal Growth Factor Humans Mice Neuregulin-1 Phosphorylation Receptor, Epidermal Growth Factor Receptor, erbB-2 Tumor Cells, Cultured Murinae
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_07302312_v90_n3_p561_Pagano
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes
por: Pagano, Eleonora, et al.
Publicado: (2003)

Expression of erythroblastic leukemia viral oncogene homolog (erbBS) mRNAs and possible splice variants in 3T3-L1 preadipocytes
Publicado: (2011)

Expression of erythroblastic leukemia viral oncogene homolog (erbBS) mRNAs and possible splice variants in 3T3-L1 preadipocytes
por: Pagano, E., et al.

Down-modulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytes
por: Pagano, Eleonora, et al.
Publicado: (2008)

Down-modulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytes
por: Pagano, E., et al.

Changes in IGF-I receptor and IGF-I mRNA during differentiation of 3T3-L1 preadipocytes
Publicado: (2002)

Changes in IGF-I receptor and IGF-I mRNA during differentiation of 3T3-L1 preadipocytes
por: Zizola, C.F., et al.

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells
por: Puricelli, Lydia Inés, et al.
Publicado: (2002)

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells
por: Puricelli, L., et al.
Publicado: (2002)

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells
por: Puricelli, L., et al.

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells
por: Puricelli, L., et al.
Publicado: (2002)

Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth
Publicado: (2009)

Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth
por: Proietti, C.J., et al.

Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction
Publicado: (2004)

Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction
por: Lidke, D.S., et al.

Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas
Publicado: (1999)

Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas
por: Balañá, M.E., et al.

GH administration patterns differently regulate epidermal growth factor signaling
Publicado: (2014)

GH administration patterns differently regulate epidermal growth factor signaling
por: Díaz, M.E., et al.

Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models
por: Simian, Marina
Publicado: (2017)

Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models
por: Toscani, A.M., et al.

Protein kinase C is differentially regulated by thrombin, insulin, and epidermal growth factor in human mammary tumor cells
por: Gómez, María Laura
Publicado: (1988)

Protein kinase C is differentially regulated by thrombin, insulin, and epidermal growth factor in human mammary tumor cells
por: Gomez, M.L., et al.

Effect of hexavalent chromium on proliferation and differentiation to adipocytes of 3T3-L1 fibroblasts
por: Martini, Claudia Noemí, et al.
Publicado: (2014)

Effect of hexavalent chromium on proliferation and differentiation to adipocytes of 3T3-L1 fibroblasts
por: Martini, C.N., et al.

Cellular fibronectin is induced by epidermal growth factor, but not by dexamethasone or cyclic AMP in rat liver epithelial cells
Publicado: (1988)

Cellular fibronectin is induced by epidermal growth factor, but not by dexamethasone or cyclic AMP in rat liver epithelial cells
por: Seebacher, T., et al.

N-acetylcysteine inhibits kinase phosphorylation during 3T3-L1 adipocyte differentiation
por: Calvo, Juan Carlos, et al.
Publicado: (2017)

N-acetylcysteine inhibits kinase phosphorylation during 3T3-L1 adipocyte differentiation
por: Soto, D., et al.

Comparative studies between freshly isolated and spontaneously immortalized bovine granulosa cells: Protein secretion, steroid metabolism, and responsiveness to growth factors
por: Colman Lerner, Alejandro Ariel, et al.
Publicado: (1995)

Comparative studies between freshly isolated and spontaneously immortalized bovine granulosa cells: Protein secretion, steroid metabolism, and responsiveness to growth factors
por: Colman Lerner, A.A., et al.

Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
Publicado: (2005)

Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
por: Hofer, E.L., et al.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Labriola, Leticia, et al.
Publicado: (2001)

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.
Publicado: (2001)

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.
Publicado: (2001)

Role of thrombin in the proliferative response of T-47D mammary tumor cells. Mitogenic action and pleiotropic modifications induced together with epidermal growth factor and insulin
Publicado: (1987)

Role of thrombin in the proliferative response of T-47D mammary tumor cells. Mitogenic action and pleiotropic modifications induced together with epidermal growth factor and insulin
por: Medrano, E.E., et al.

Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells
Publicado: (2003)